BillionToOne, Inc.
NASDAQ · us_market
No AI summary generated yet for this ticker.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.
During the quarter, we added 9 new positions and exited 11 positions, bringing the number of positions in the Fund to 41.
The United States market has experienced a robust performance, with a 1.2% increase over the last week and a substantial 29% rise over the past year, while earnings are anticipated to grow by 17% annually in the coming years. In this environment, growth companies with significant insider ownership can be particularly appealing as they often align management interests with shareholder value and may indicate confidence in the company's future prospects.
The average of price targets set by Wall Street analysts indicates a potential upside of 37% in BillionToOne (BLLN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
This cloud-based payments provider delivers SaaS solutions to enterprise billers across utilities, finance, and healthcare sectors.
BillionToOne, Inc. (NASDAQ:BLLN) was among Jim Cramer’s Mad Money stock calls as he urged investors to exercise caution when it comes to red-hot AI stocks. Toward the end of the lightning round, a caller sought Cramer’s opinion on the stock, and he commented: We like BillionToOne. We looked at it, we thought the name was […]
Cramer likes Silicon Motion, whose shares fell 2.2% to settle at $263.85 on Thursday. Wynn shares declined 0.8% to close at $95.43.
When companies post strong earnings, the stock generally performs well, just like BillionToOne, Inc.'s ( NASDAQ:BLLN...
Guggenheim analyst Subbu Nambi maintains BillionToOne (NASDAQ:BLLN) with a Buy and raises the price target from $100 to $120.
Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings projected to grow at an annual rate of 16%. In such a thriving market environment, identifying stocks that are estimated to be trading below their intrinsic value can present unique opportunities for investors seeking potential growth and value.
Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings projected to grow at an annual rate of 16%. In such a thriving market environment, identifying stocks that are estimated to be trading below their intrinsic value can present unique opportunities for investors seeking potential growth and value.
The mean of analysts' price targets for BillionToOne (BLLN) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The mean of analysts' price targets for BillionToOne (BLLN) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
JP Morgan analyst Casey Woodring maintains BillionToOne (NASDAQ:BLLN) with a Overweight and raises the price target from $120 to $125.
Moby summary of BillionToOne, Inc.'s Q1 2026 earnings call
BTIG analyst Mark Massaro maintains BillionToOne (NASDAQ:BLLN) with a Buy and lowers the price target from $140 to $130.
Billiontoone (NASDAQ:BLLN) reported first-quarter 2026 results showing rapid revenue growth alongside GAAP profitability, driven by higher test volumes, rising average selling prices (ASPs), and expanding gross margins. Management also highlighted the launch of a new prenatal confirmation offering,
Billiontoone (NASDAQ:BLLN) reported first-quarter 2026 results showing rapid revenue growth alongside GAAP profitability, driven by higher test volumes, rising average selling prices (ASPs), and expanding gross margins. Management also highlighted the launch of a new prenatal confirmation offering,
BillionToOne Q1 revenue of $108.4M and EPS $0.34 crushed estimates, driving shares up 5%+ after-hours. The diagnostics firm raised its full-year revenue guidance to $450-465M.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 82.8K | $6.53M | 0.01% | New | 2026-03-31 |
| RenTech | quant | 51.3K | $4.05M | 0.01% | New | 2026-03-31 |
| StateStreet | passive | 19.7K | $1.56M | 0.00% | Trimmed-8.8% | 2026-03-31 |
| Soros | macro | 14.5K | $1.14M | 0.01% | Unchanged | 2026-03-31 |
| DEShaw | quant | 3.9K | $304.87K | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 737.5K | $58.22K | 0.01% | Added+52.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-05upcoming | 0.16 | — | — |
| 2026-03-04 | 0.17 | 0.15 | -10.55% |
| 2025-12-10 | 0.16 | 0.91 | +468.75% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BLLN | +27.75% | +19.06% | +20.96% | — |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +24.78% | +23.70% | +24.40% | — |